Latest News
Mucovac2 HIV vaccine starts enrolment
Mucovac2 HIV vaccine starts enrolment
Bevacizumab may improve survival in ovarian cancer
Bevacizumab may improve survival in ovarian cancer
CTU website launches new methodology section
CTU website launches new methodology section
Trial of HIV treatment timing reaches recruitment halfway point
Trial of HIV treatment timing reaches recruitment halfway point
Treating South African infants with HIV early, and then interrupting their treatment, leads to better results
Treating South African infants with HIV early, and then interrupting their treatment, leads to better results than deferring initial treatment